Market Cap
₹30,004 Cr.
P/E
54.82
Quick View
  • 1d
  • 1m
  • 6m
  • YTD
  • 1y
  • 3y
  • 5y
  • 10y
  • max

Company Timeline

Forensics

10 Yes

Positive for this company

2 Neutral

Neutral for this company

5 No

Negative for this company

0 No Data

Insufficient data to analyse

ROE
Latest
8.07%
3yr Average
16.16%
5yr Average
15.9%
Net Profit Margin
Latest
7.6%
3yr Average
14.66%
5yr Average
13.8%
ROCE
Latest
11.64%
3yr Average
19.61%
5yr Average
18.97%
Debt to Equity
Latest
0.25
3yr Average
0.15
5yr Average
0.15
Market Share
0.81% (as of Jul 22)
Anti - Diabetes - Market Share
1.03% (as of Jul 22)
Anti-Infectives - Market Share
55.08% (as of Nov 21)
Anti-Malarial - Market Share
3.84% (as of Nov 21)
Antineo Plastic - Market Share
0.11% (as of Nov 21)
Blood Related - Market Share
2.09% (as of Jul 22)
Cardiovascular - Market Share
1.20% (as of Nov 21)
Dermatology - Market Share
0.12% (as of Nov 21)
Endocrinology - Market Share
1.02% (as of Jul 22)
Gastro-Intestinal - Market Share
1.11% (as of Nov 21)
Neurological - Market Share
0.55% (as of Nov 21)
Ophthalmology - Market Share
8.06% (as of Nov 21)
Pain - Market Share
1.80% (as of Dec 22)
Pharmaceutical Sector - Market Share
0.83% (as of Nov 21)
Respiratory - Market Share
0.39% (as of Jul 22)
Sex Stimulants - Market Share
2.23% (as of Nov 21)
Urology - Market Share
0.43% (as of Jul 22)
Vitamin & Dietary Supplements - Market Share
Show more
Revenue mix

Product Wise Break-Up

locked
Source
|
Latest
|
locked
Historic

Therapeutic Area Wise Break-Up - Domestic

locked
Source
|
Latest
|
locked
Historic

Location Wise Break-Up -Branded Generics

locked
Source
|
Latest
|
locked
Historic

Location Wise Break-Up -Generics

locked
Source
|
Latest
|
locked
Historic

Location Wise Break-Up -API

locked
Source
|
Latest
|
locked
Historic

Location Wise Break-Up

locked
Source
|
Latest
|
locked
Historic

Therapeutic Area Break-Up

locked
Source
|
Latest
|
locked
Historic
Show more
Operational Metrics

    Select a Metric
    • US DMF Filings (.)
    • Number of ANDA's Filed in USA (.)
    • Number of ANDA's Approved By USFDA (.)
    • Domestic Sales Growth - YoY (%)
    • R&D as a % of Total Sales (%)
    Peer Comparison
    Suppliers
    Company Filing
    Show Previous Years
    Discussions & Analysis